Researchers looked at data from over 2,000 patients who had surgery to see if adding specific movements could prevent deep vein thrombosis (DVT). DVT is a serious condition where blood clots form in the deep veins, often in the legs. The study compared patients receiving standard anticoagulant therapy alone against those who also performed ankle pump exercises.
The results showed that patients who did ankle pumps along with their medication had a significantly lower risk of developing blood clots. Specifically, active ankle pump exercises showed a consistent protective effect. This suggests that simple physical movements might be a helpful addition to standard medical treatments for preventing clots after surgery.
It is important to note that the quality of the evidence is currently low because the original studies had some flaws and differences. Because the data is not yet definitive, these findings should be viewed as an early indication rather than a proven rule. Patients should talk to their doctors about whether adding these exercises is right for their specific recovery plan.
Common questions
What is deep vein thrombosis (DVT)?
Deep vein thrombosis, or DVT, is a condition where a blood clot forms in a deep vein, most commonly in the legs. It can occur after surgery when mobility is limited. This study looked at how adding ankle pump exercises to standard medication could help lower the risk of these clots forming during recovery.
How do ankle pumps help after surgery?
The study found that combining ankle pump exercises with anticoagulant therapy significantly reduced the risk of DVT compared to using medication alone. Active ankle pump exercises showed a consistent protective effect in the data, suggesting they may be a helpful addition to standard care for patients at risk of blood clots.
Is this finding certain enough to change treatment?
The evidence is currently considered low quality due to flaws in the original studies and differences between them. While the results show a link between ankle pumps and lower DVT risk, doctors should be cautious. More high-quality trials are needed before these findings can be fully confirmed as a standard practice.
